Home > Boards > US Listed > Miscellaneous > CryoPort Inc. (CYRX)

Well so far the market appears to like

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
hyperopia Member Profile
 
Followed By 8
Posts 350
Boards Moderated 0
Alias Born 09/10/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/9/2020 4:54:46 PM
Cryoport Announces Preliminary Fourth Quarter and Full Year 2019 Revenue PR Newswire (US) - 1/9/2020 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 10:32:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 10:31:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/19/2019 4:20:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/22/2019 6:25:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/21/2019 5:44:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/15/2019 6:01:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/14/2019 5:12:54 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 1:03:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 4:28:15 PM
Cryoport Revenue Grows 81% for Third Quarter 2019 PR Newswire (US) - 11/7/2019 4:05:00 PM
Lonza Partners with Cryoport and Strengthens its 'Vein-to-vein' Delivery Network in Cell & Gene Therapy PR Newswire (US) - 11/5/2019 9:00:00 AM
Cryoport to Report Third Quarter 2019 Financial Results on November 7, 2019 PR Newswire (US) - 10/31/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2019 6:14:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2019 12:20:08 PM
Cryoport Authorizes Share Repurchase Program and Presenting at Upcoming Investor Conferences PR Newswire (US) - 10/9/2019 9:00:00 AM
Adaptimmune and Cryoport Announce Agreement to Ensure Safe and Fully Monitored Transport of Adaptimmune’s Cell Therapies GlobeNewswire Inc. - 10/9/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 7:15:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 7:12:18 PM
Cryoport Introduces Cell & Gene Industry's First Dedicated Shipper for Advanced Therapies PR Newswire (US) - 9/18/2019 8:30:00 AM
Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Market GlobeNewswire Inc. - 9/4/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2019 12:36:26 PM
BriaCell Appoints Richard J. Berman to Board of Directors GlobeNewswire Inc. - 8/12/2019 6:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 5:21:30 PM
hyperopia   Wednesday, 05/15/19 11:26:24 AM
Re: None
Post # of 11964 
Well so far the market appears to like it, but it will be interesting to see the details on this transaction. I can only find limited information about this tiny, private company. Appears to be about 5-10 employees, and between $1-5M in sales. Some of their facilities appear to be modern, and others? Not so much. . . http://cryogenelab.com/pricing/


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist